Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2026)

Arcturus Therapeutics Holdings has reported Other Non Operating Income for 9 years, with the latest figure at $35000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 266.67% year-over-year to $35000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.8 million (down 180.64% YoY), and the FY2025 full-year result was $382000.0, down 97.49% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $35000.0, up from -$8.2 million in the prior quarter.
• The five-year high for Other Non Operating Income was $34.1 million in Q4 2023, with the low at -$8.2 million in Q4 2025.
• Historically, Other Non Operating Income has averaged $2.1 million across 5 years, with a median of $4000.0 in 2023.
• The largest YoY upside for Other Non Operating Income was 2683.89% in 2024 against a maximum downside of 5125.0% in 2024.
• Arcturus Therapeutics Holdings' Other Non Operating Income stood at -$3.8 million in 2022, then surged by 989.91% to $34.1 million in 2023, then tumbled by 90.58% to $3.2 million in 2024, then plunged by 354.82% to -$8.2 million in 2025, then jumped by 100.43% to $35000.0 in 2026.
• The last three Other Non Operating Income figures came in at $35000.0 (Q1 2026), -$8.2 million (Q4 2025), and -$170000.0 (Q3 2025), per Business Quant data.